Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides.
The aim of the present study was to delineate the functional domains of nociceptin (noc), a neuropeptide which is structurally related to dynorphin A (dyn). The binding and biological potencies towards the nociceptin (ORL1) and dynorphin A (kappa-opioid) receptors of twenty dyn/noc and noc/dyn hybrid peptides were compared with those of the parent heptadecapeptides. Replacement of as many as eleven residues in the C-terminus of dynorphin by the corresponding nociceptin sequence has no significant effect on binding and biological activity towards the kappa-opioid receptor. In marked contrast, replacement of as few as six residues (RKLANQ) in the C-terminus of nociceptin by the corresponding dynorphin sequence (LKWDNQ) dramatically impairs both affinity and activity towards the ORL1 receptor. This clearly indicates that the two neuropeptides have different functional architectures, despite the dual structural homology of both ligands and receptors. Moreover, the recombinant peptide approach led us to identify hybrids whose sequences differ only at positions 5 and 6 and displaying opposite or no receptor selectivity. One contains the dynorphin Leu5-Arg6 sequence and prefers the kappa-opioid receptor, whereas the other comprises the nociceptin Thr5-Gly6 sequence and prefers the ORL1 receptor. A third, containing the mixed dynorphin/nociceptin Leu5-Gly6 sequence, does not discriminate between the two types of receptor.
Lapalu
S
S
Unité de Neuropharmacologie Moléculaire, Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Toulouse, France.
Moisand
C
C
Mazarguil
H
H
Cambois
G
G
Mollereau
C
C
Meunier
J C
JC
D000595:Amino Acid Sequence; D000818:Animals; D001667:Binding, Competitive; D016466:CHO Cells; D002462:Cell Membrane / Q000378:metabolism; D006224:Cricetinae; D004174:Diprenorphine / Q000378:metabolism; D004399:Dynorphins / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008969:Molecular Sequence Data; D018847:Opioid Peptides / Q000737:chemistry / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology; D011957:Receptors, Opioid / Q000096:biosynthesis / Q000502:physiology*; D017473:Receptors, Opioid, kappa / Q000096:biosynthesis / Q000502:physiology*; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000494:pharmacology; D011994:Recombinant Proteins / Q000096:biosynthesis; D016415:Sequence Alignment; D013329:Structure-Activity Relationship; D000094942:Nociceptin Receptor; D000097629:Nociceptin
D004174:Diprenorphine; D004399:Dynorphins; D018847:Opioid Peptides; D010455:Peptides; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D000094942:Nociceptin Receptor; D000097629:Nociceptin